| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$9 |
Equity Raising Presentation
|
17 Nov 2025 9:40AM |
$0.022 |
$0.009 |
fallen by
59.09%
|
|
GEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Genmin Limited seeks to raise A$25.7 million through a two-tranche placement.
- Funds aim to progress Baniaka Iron Ore Project and repay director loans.
- Collaboration with PowerChina for project delivery and funding.
- Target to achieve final investment decision by mid-2026.
- Focus on developing Baniaka as a producer of greener, high-quality iron ore.
- Cost optimization initiatives to enhance financial stability.
- Engagement with institutional and strategic investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$4 |
Record Growth in Seaweed Sales
|
17 Nov 2025 9:39AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BP8’s Indonesian subsidiary, PT BPH Global Indonesia, achieved significant sales growth during October.
- PT BPH Global Indonesia generated IDR 2,970,000,000 in independent sales.
- The company also had IDR 2,960,000,000 in sales through a partnership with PT Kebula Raya Bestari.
- October's sales period resulted in record gross sales of approximately A$551,627.
- BP8's sales more than doubled compared to the previous record month.
- The Makassar warehouse plays a critical role in efficient processing and logistics.
- BP8 received an Indonesian Seaweed Export Licence, enabling direct international shipments.
- The company is focused on expanding its customer base and production scalability.
- BPH Global Ltd authorized the release of the sales performance by its board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$9 |
Proposed issue of securities - GEN
|
17 Nov 2025 9:39AM |
$0.022 |
$0.009 |
fallen by
59.09%
|
|
| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$76 |
Proposed issue of securities - CRI
|
17 Nov 2025 9:39AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$76 |
Proposed issue of securities - CRI
|
17 Nov 2025 9:39AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$29,247 |
Prospectus Supplement
|
17 Nov 2025 9:39AM |
$13.180 |
$12.670 |
fallen by
3.87%
|
|
| Genmin Limited (GEN) ORDINARY FULLY PAID |
Materials |
$9 |
A$25.7 million placement, including director participation
|
17 Nov 2025 9:39AM |
$0.022 |
$0.009 |
fallen by
59.09%
|
|
GEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Genmin Limited raised A$25.7 million via a two-tranche placement.
- Directors committed A$8.3 million through loan conversions.
- Funds to advance Baniaka iron ore project and cover costs.
- Joint lead managers were Foster Stockbroking and Canaccord Genuity.
- First tranche unconditional; second tranche subject to shareholder approval.
- Extraordinary General Meeting scheduled for 16 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$76 |
Critica Secures $8 Million in Oversubscribed Placement
|
17 Nov 2025 9:39AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
CRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Critica Limited raises approximately A$8 million in an oversubscribed placement.
- The placement will support the Jupiter rare earths project in Western Australia.
- 307.7 million shares will be issued at A$0.026 per share.
- Includes a 1:1 free attaching option exercisable at $0.043 per share.
- Funds will advance the Jupiter REE Scoping Study, drilling, and other strategic initiatives.
- Bell Potter Securities Limited and Taylor Collison Limited acted as joint lead managers.
- The placement includes two tranches, with Tranche 2 pending shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Propel Funeral Partners (PFP) ORDINARY FULLY PAID |
Consumer Discretionary |
$691 |
Notification regarding unquoted securities - PFP
|
17 Nov 2025 9:39AM |
$4.820 |
$5.010 |
risen by
3.94%
|
|
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$29 |
AGM Presentation to Shareholders
|
17 Nov 2025 9:38AM |
$0.010 |
$0.011 |
risen by
10%
|
|
LML - Price-sensitive ASX Announcement
Full Release
Key Points
- Focus on Kookaburra Graphite Project with high-grade surface graphite.
- Minbrie Project shows promising base metal potential over 7km strike.
- Significant uranium targets identified in the Eyre Peninsula.
- Positioned to support a domestic green steel industry with iron ore projects.
- Strong leadership team with a track record in exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critica Limited (CRI) ORDINARY FULLY PAID |
Materials |
$76 |
Critica's MREP flowsheet achieves 63% Gallium leach updated
|
17 Nov 2025 9:38AM |
$0.031 |
$0.026 |
fallen by
16.13%
|
|
CRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Critica's MREP flowsheet achieves 63% gallium leach recovery.
- Jupiter Project's 1.8 billion-tonne resource contains 70,000 tonnes of gallium.
- Gallium co-recovery enhances economic potential without additional processing steps.
- China controls over 98% of global gallium supply, underlining strategic importance.
- Ongoing trials to optimize gallium extraction and define product specifications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$67 |
Monthly Funds Under Management - 31 October 2025
|
17 Nov 2025 9:36AM |
$0.690 |
$0.680 |
fallen by
1.45%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Pengana Capital Group Limited announced funds under management (FUM) of $3,840.24 million as of 31 October 2025.
- The FUM as of 30 September 2025 was $3,770.10 million, showing an increase by the end of October.
- An additional $69.10 million was raised under the Entitlement and Shortfall Offers for the Pengana Global Private Credit Trust, to be recognized in November 2025.
- The announcement was approved by Paula Ferrao, the Company Secretary.
- For enquiries, Paula Ferrao and Pengana Client Service are the designated contacts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adisyn Ltd (AI1) ORDINARY FULLY PAID |
Information Technology |
$44 |
Key Milestone Achieved in AI1 Graphene Deposition Process
|
17 Nov 2025 9:36AM |
$0.076 |
$0.061 |
fallen by
19.74%
|
|
AI1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Key technical milestone achieved in graphene deposition process.
- Validation of a sub-process within the pre-clean stage completed.
- Process architecture is ready for broader deposition trials.
- Aimed at enabling graphene growth on semiconductor wafers.
- Low-temperature ALD approach allows graphene growth at semiconductor-compatible temperatures.
- International collaborations support the development.
- Development roadmap extends through late 2025 and into 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$22,390 |
PME signs 5-year, A$44M deal Advanced Radiology Management
|
17 Nov 2025 9:36AM |
$248.830 |
$214.240 |
fallen by
13.90%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- PME signs 5-year, A$44M contract with Advanced Radiology Management, LLC.
- Contract is for Visage 7 Viewer implementation in the cloud.
- Based on a transactional licensing model with potential upside.
- Planning for immediate rollout with late Q2 2026 Go-Live target.
- Collaboration aims to improve radiologist efficiency and reduce burnout.
- Strengthens Pro Medicus' presence in the North American healthcare IT market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$480 |
Weekly NTA Update
|
17 Nov 2025 9:35AM |
$1.990 |
$1.950 |
fallen by
2.01%
|
|
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$54 |
Columbia Partnership Accelerates US REE Processing Strategy
|
17 Nov 2025 9:34AM |
$0.340 |
$0.190 |
fallen by
44.12%
|
|
LKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Locksley collaborates with Columbia University for REE processing.
- Focus on sustainable and advanced electrochemical recovery technologies.
- AI-driven ore characterization to support U.S. critical mineral supply chains.
- Joint pursuit of DOE and DoW funding for pilot-scale development.
- Partnership complements Locksley's work with Rice University.
- Aligns with U.S. government priorities for critical mineral independence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clever Culture Systems Limited (CC5) ORDINARY FULLY PAID |
Health Care |
$61 |
New Customer Data Shows APAS Delivers Proven Value
|
17 Nov 2025 9:34AM |
$0.031 |
$0.028 |
fallen by
9.68%
|
|
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$380 |
Weekly NTA Update
|
17 Nov 2025 9:33AM |
$2.410 |
$2.570 |
risen by
6.64%
|
|
| Ingenia Communities Group (INA) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$2,130 |
Notification regarding unquoted securities - INA
|
17 Nov 2025 9:33AM |
$5.280 |
$5.225 |
fallen by
1.04%
|
|
| Propel Funeral Partners (PFP) ORDINARY FULLY PAID |
Consumer Discretionary |
$691 |
Notification regarding unquoted securities - PFP
|
17 Nov 2025 9:32AM |
$4.820 |
$5.010 |
risen by
3.94%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$5,678 |
2025 Corporate Governance Statement & Appendix 4G
|
17 Nov 2025 9:32AM |
$3.400 |
$3.170 |
fallen by
6.76%
|
|
| Patriot Resources Limited (PAT) ORDINARY FULLY PAID |
Materials |
$8 |
Trench Assays Expand Cu-Zn-Pb Footprint at Kitumba
|
17 Nov 2025 9:31AM |
$0.040 |
$0.046 |
risen by
15%
|
|
PAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant Cu-Zn-Pb assays received from Phase 1 trenching at Kitumba
- Expanded mineralized footprint to ~200m strike length and 20-35m width
- Key results include 0.99% Cu, 0.93% Zn over 2.0m from TBTR03
- Ground magnetics and IP surveys underway to refine drilling targets
- Potential polymetallic Cu-Zn-Pb-Au system identified
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$8 |
Proposed issue of securities - VFX
|
17 Nov 2025 9:31AM |
$0.002 |
$0.090 |
risen by
4,400%
|
|
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$53 |
Share Purchase Plan Booklet
|
17 Nov 2025 9:30AM |
$0.032 |
$0.030 |
fallen by
6.25%
|
|
| Aurora Labs Limited (A3D) ORDINARY FULLY PAID |
Industrials |
$24 |
MOU Executed with Ares Armaments
|
17 Nov 2025 9:30AM |
$0.049 |
$0.048 |
fallen by
2.04%
|
|
A3D - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurora Labs (A3D) enters MOU with Ares Armaments.
- Focus on R&D for small, high-performance defence components.
- Use of exotic metals and advanced manufacturing techniques.
- Prototyping and testing expected in Q1 CY26.
- Partnership enhances A3D's role in sovereign defence manufacturing.
- Potential for large-scale production and government engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.